What you know matters when it comes to navigating breast cancer. Whether diagnosed with early-stage or living with metastatic breast cancer, having trusted resources and information provides a roadmap that helps people to find the best way forward for living well beyond their diagnosis.
This four-part series features discussions that will help individuals further understand their options by providing insight on breakthroughs in treatments, the role of testing, and navigating the cost of cancer care.
The sessions will empower both those diagnosed with early-stage and metastatic breast cancer to make informed decisions about their care and provide strategies to help them advocate for themselves throughout treatment and beyond.
Please email programs@lbbc.org by Tuesday, September 3 to request ASL interpretation
On this page
Session information
Session 1 | Shared decision making and patient choices
Tuesday, September 17 | 12:00- 1:00pm (ET)
Speakers: Blakeley Schmidt Anderson; Don Dizon, MD, FACP, FASCO
Moderator: Amelia O'Relly
In this age of personalized medicine, treatment decision making can be a complex matter. This program will help you understand why there are standards of care in breast cancer treatment, how they impact your treatment decisions, and how to advocate for standard of care if you think you are not receiving the care you deserve.
Session 2 | Innovations in treatment and side effect management
Wednesday, September 25 | 12:00- 1:00pm (ET)
Speaker: Eleonora Teplinsky, MD
Learn about the latest breakthroughs in targeted treatment, how these treatments are administered, the short-term and long-term impacts of chemotherapy and strategies for managing these side effects. We will also explore the evolution beyond chemotherapy, oral therapies that may make treatment more convenient and ways that personalized medicine may impact your treatment plan and provide you with options.
Session 3 | Understanding testing in breast cancer
Tuesday, October 1 | 12:00 – 1:00pm (ET)
Speaker: Reshma Mahtani, DO
This session will explain the role of testing in breast cancer today. Learn about the tests that look for mutations, or changes, in tumors and in the blood and are used to develop a tailored treatment plan for your personalized care.
Session 4 | Practical matters: The financial and time toxicity of breast cancer
Wednesday, October 9 |12:00 - 1:00pm (ET)
Speakers: Erin Bradshaw; Pallav Mehta, MD
The term financial toxicity describes both the practical and the emotional impact of the cost of care on individuals and families managing a cancer diagnosis. This session will explain the factors that contribute to financial toxicity, explore their impact, and provide ways to reduce or overcome obstacles. Hear about useful resources to assist with everyday bills, manage costs, and eliminate barriers to quality healthcare.
Speakers
Blakeley Schmidt Andersen
Patient Advocate
Erin Bradshaw
Executive Vice President for the Advancement of Patient Services and Navigation, Patient Advocate Foundation
Don S. Dizon, MD, FACP, FASCO
Director, The Pelvic Malignancies Program, Lifespan Cancer Institute
Reshma L. Mahtani, DO
Chief of Breast Medical Oncology, Miami Cancer Institute, Baptist Health South Florida
Pallav K. Mehta, MD
Medical Director, Reimagine Care; Assistant Professor of Medicine, MD Anderson Cancer Center at Cooper
Amelia O'Relly
Patient Advocate
Eleonora Teplinsky, MD
Head, Breast and Gynecological Medical Oncology, Valley-Mount Sinai Comprehensive Cancer Care
Thank you
Presenting sponsor
Title sponsor
Signature sponsors
Benefactor
Related resources
Stay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
